Merchavia Holdings and Investments Ltd (TLV:MRHL)
Israel · Delayed Price · Currency is ILS · Price in ILA 173.20
-5.00 (-2.81%)
Aug 13, 2026, 1:29 PM IDT
TLV:MRHL Market Cap
TLV:MRHL has a market cap or net worth of 37.07 million as of August 13, 2026. Its market cap has increased by 91.43% in one year.
Market Cap
37.07M
Enterprise Value
37.46M
Revenue
44.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
173.20
ChartMarket Cap Chart
Since April 1, 2009, TLV:MRHL's market cap has increased from 16.01M to 37.07M, an increase of 131.56%. That is a compound annual growth rate of 4.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 37.07M | -18.10% |
| Dec 31, 2025 | 45.26M | 333.07% |
| Dec 31, 2024 | 10.45M | -34.17% |
| Dec 31, 2023 | 15.87M | -41.25% |
| Dec 28, 2022 | 27.02M | -52.87% |
| Dec 29, 2021 | 57.32M | 3.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 126.32B |
| Danel (Adir Yeoshua) | 2.56B |
| Amal Holdings A.D. | 2.33B |
| BrainsWay | 1.82B |
| Almeda Ventures Limited Partnership | 42.75M |
| Together Pharma | 41.20M |
| BioLineRx | 39.31M |
| Clal Biotechnology Industries | 38.11M |